(Q36960553)

17 August 2017

1 reference

title

Drug interactions involving ethanol and alcoholic beverages (English)

1 reference

17 August 2017

1 reference

Graham R Jang

1

1 reference

17 August 2017

Robert Z Harris

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Drug Metabolism & Toxicology

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

719-731

1 reference

Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effect of food and food composition on alcohol elimination rates in healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Induction of CYP3A by ethanol in multiple in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Pre-operative alcohol infusion. The need for analgesic supplementation in chronic alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Acetaminophen hepatotoxicity: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Paracetamol, alcohol and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Acetaminophen misconceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effects of energy drink ingestion on alcohol intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Gamma-hydroxybutyrate and ethanol effects and interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Mechanism-based inactivation of CYP3A by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

The effects of acute ethanol intake on isoniazid pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Acetylator phenotyping: the effect of ethanol on the dapsone test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Alcohol-associated rapid release of a long-acting opioid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Controlled-release opioids and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effect of common over-the-counter medications on blood alcohol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Do ethanol and metronidazole interact to produce a disulfiram-like reaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Lack of disulfiram-like reaction with metronidazole and ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Images in clinical medicine. Tacrolimus ointment, alcohol, and facial flushing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Tacrolimus ointment-associated alcohol intolerance in infants receiving ethanol-containing medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Alcohol-induced rash caused by topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Alcohol ingestion and topical tacrolimus: a disulfiram-like interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Alcohol intolerance and facial flushing in patients treated with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effects of calcium channel inhibitors on ethanol effects and pharmacokinetics in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Interaction between ethanol and calcium channel blockers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Inhibition of carcinogenesis by isothiocyanates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Watercress has no Importance for the elimination of ethanol by CYP2E1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Honey-induced stimulation of blood ethanol elimination and its influence on serum triacylglycerol and blood pressure in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effect of high-fat, high-protein, and high-carbohydrate meals on the pharmacokinetics of a small dose of ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Resveratrol is a selective human cytochrome P450 1A1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Red wine-cisapride interaction: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

Effects of light and dark beer on hepatic cytochrome P-450 expression in male rats receiving alcoholic beverages as part of total enteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.5.719

21 January 2018

Identifiers

DOI

10.1517/17425255.3.5.719

1 reference

17 August 2017

1 reference